Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-009621
Filing Date
2025-04-02
Accepted
2025-04-02 16:05:13
Documents
1
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 form4-04022025_040409.html 4  
1 form4-04022025_040409.xml 4 3606
  Complete submission text file 0001415889-25-009621.txt   5486
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Reporting) CIK: 0001429260 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38114 | Film No.: 25804301
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

EIN.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)